J&J Preview: The Doctor Is In (at CNBC)

JOHNSON & JOHNSON (JNJ) Dow Component. Some companies focus on drugs, others on medical devices, still others keep it simple making bandages. J&J does it all. Risperdal and Remicade are just two of the drugs from the company's Pharmaceuticals division. The Medical Devices and Diagnostics unit produces everything from surgical equipment to stents to contact lenses. And of course, the Consumer Products division makes shampoo, first aid and a host of other well-known products. Largest player in the health care sector with a market cap of about $170 billion. Reports Q3 earnings Thursday 10/14 at approx. 800a ET. Conference call at 830a ET. WHAT WILL MOVE THE STOCK: RISPERDAL CHALLENGE - Is generic competition taking a bigger-than-expected bite out of Risperdal sales? Patent protection for this antidepressant drug expired this... [read full story]